Literature DB >> 17277710

An association of intrusive, repetitive phrases with lamotrigine treatment in bipolar II disorder.

David E Kemp1, William S Gilmer, Jenelle Fleck, Pedro L Dago.   

Abstract

INTRODUCTION: Bipolar disorder is frequently associated with obsessional symptoms. However, no reports have identified a pattern of obsessionality that is associated with a specific mood stabilizer treatment.
METHODS: A chart review was conducted on five patients with bipolar II disorder who spontaneously reported a form of obsessionality characterized by intrusive, recurrent phrases after taking lamotrigine.
RESULTS: Development of the phrases occurred from 7-42 years after mood disorder onset and occurred only after initiation of lamotrigine treatment. The phrases improved with lamotrigine discontinuation or dose reduction and recurred with lamotrigine re-challenge or upon dose escalation.
CONCLUSION: A possible mechanism for the development of the intrusive phrases involves the influence of lamotrigine on glutamatergic regulation in a bipolar II disorder population vulnerable to the expression of obsessionality. Limitations of this report include its observational nature, small number of cases reported, and confound of concomitant medication use.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277710     DOI: 10.1017/s1092852900020617

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  5 in total

Review 1.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors:  Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal:  Pharmacol Ther       Date:  2011-09-22       Impact factor: 12.310

2.  Compulsive gambling possibly associated with antiepileptic medication.

Authors:  Susanne Storrier; Roy G Beran
Journal:  Epilepsy Behav Case Rep       Date:  2014-01-08

3.  Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications.

Authors:  Alejandro Szmulewicz; Cecilia Samamé; Pablo Caravotta; Diego J Martino; Ana Igoa; Diego Hidalgo-Mazzei; Francesc Colom; Sergio A Strejilevich
Journal:  Int J Bipolar Disord       Date:  2016-02-16

Review 4.  Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.

Authors:  Zoya Marinova; De-Maw Chuang; Naomi Fineberg
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

5.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.